12:52 PM EST - Biovail Corp. : shares moved up after the drug company unveiled a new strategic plan to focus on central nervous system disorders, close its Puerto Rico operations and sell non-core assets. Biovail also reported first-quarter profit moved down to $56.4 million from $93.8 million a year ago. Revenues dropped to $208.5 million, compared with $247 million a year before. Biovail Corp.
shares T.BVF are trading up 67 cents at $12.51.
